In June, we added 106 citations in DIDB, including 48 in vitro (with 15 articles published in June 2026) and 58 in vivo articles (with 36 articles published in June 2026).
4 drugs approved by the FDA from March to May in 2026, including icotrokinra (ICOTYDE), bulevirtide (HEPCLUDEX), pivekimab sunirine (DECNUPAZ), and vepdegestrant (VEPPANU), were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.